|
1
|
Yu W, Zhu J, Wang Y, Wang J, Fang W, Xia
K, Shao J, Wu M, Liu B, Liang C, et al: A review and outlook in the
treatment of osteosarcoma and other deep tumors with photodynamic
therapy: From basic to deep. Oncotarget. 8:39833–39848.
2017.PubMed/NCBI
|
|
2
|
Nouri H, Ben Maitigue M, Abid L, Nouri N,
Abdelkader A, Bouaziz M and Mestiri M: Surface osteosarcoma:
Clinical features and therapeutic implications. J Bone Oncol.
4:115–123. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Anderson ME: Update on survival in
osteosarcoma. Orthop Clin North Am. 47:283–292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miao J, Wu S, Peng Z, Tania M and Zhang C:
MicroRNAs in osteosarcoma: Diagnostic and therapeutic aspects.
Tumour Biol. 34:2093–2098. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liang WL, Cao J, Xu B, Yang P, Shen F, Sun
Z, Li WL, Wang Q and Liu F: miR-892a regulated PPP2R2A expression
and promoted cell proliferation of human colorectal cancer cells.
Biomed Pharmacother. 72:119–124. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang C, Long F, Wan J, Hu Y and He H:
MicroRNA-205 acts as a tumor suppressor in osteosarcoma via
targeting RUNX2. Oncol Rep. 35:3275–3284. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu ZF, Liang ZQ, Li L, Zhou YB, Wang ZB,
Gu WF, Tu LY and Zhao J: miR-335 functions as a tumor suppressor
and regulates survivin expression in osteosarcoma. Eur Rev Med
Pharmacol Sci. 20:1251–1257. 2016.PubMed/NCBI
|
|
8
|
Ma C, Zhan C, Yuan H, Cui Y and Zhang Z:
MicroRNA-603 functions as an oncogene by suppressing BRCC2 protein
translation in osteosarcoma. Oncol Rep. 35:3257–3264. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jin S, Dai Y, Li C, Fang X, Han H and Wang
D: MicroRNA-544 inhibits glioma proliferation, invasion and
migration but induces cell apoptosis by targeting PARK7. Am J
Transl Res. 8:1826–1837. 2016.PubMed/NCBI
|
|
10
|
Zhi Q, Guo X, Guo L, Zhang R, Jiang J, Ji
J, Zhang J, Zhang J, Chen X, Cai Q, et al: Oncogenic miR-544 is an
important molecular target in gastric cancer. Anticancer Agents Med
Chem. 13:270–275. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dai G, Zheng D, Wang Q, Yang J, Liu G,
Song Q, Sun X, Tao C, Hu Q, Gao T, et al: Baicalein inhibits
progression of osteosarcoma cells through inactivation of the
Wnt/β-catenin signaling pathway. Oncotarget. 8:86098–86116. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Feng ZY, Xu XH, Cen DZ, Luo CY and Wu SB:
miR-590-3p promotes colon cancer cell proliferation via
Wnt/β-catenin signaling pathway by inhibiting WIF1 and DKK1. Eur
Rev Med Pharmacol Sci. 21:4844–4852. 2017.PubMed/NCBI
|
|
14
|
Leung JY, Kolligs FT, Wu R, Zhai Y, Kuick
R, Hanash S, Cho KR and Fearon ER: Activation of AXIN2 expression
by beta-catenin-T cell factor. A feedback repressor pathway
regulating Wnt signaling. J Biol Chem. 277:21657–21665. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peng Z, Wu T, Li Y, Xu Z, Zhang S, Liu B,
Chen Q and Tian D: MicroRNA-370-3p inhibits human glioma cell
proliferation and induces cell cycle arrest by directly targeting
β-catenin. Brain Res. 1644:53–61. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Eo HJ, Park GH and Jeong JB: Inhibition of
Wnt signaling by silymarin in human colorectal cancer cells. Biomol
Ther (Seoul). 24:380–386. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang W, Shen C, Li C, Yang G, Liu H, Chen
X, Zhu D, Zou H, Zhen Y, Zhang D and Zhao S: miR-577 inhibits
glioblastoma tumor growth via the Wnt signaling pathway. Mol
Carcinog. 55:575–585. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
van Kouwenhove M, Kedde M and Agami R:
MicroRNA regulation by RNA-binding proteins and its implications
for cancer. Nat Rev Cancer. 11:644–656. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li WH, Wu HJ, Li YX, Pan HG, Meng T and
Wang X: MicroRNA-143 promotes apoptosis of osteosarcoma cells by
caspase-3 activation via targeting Bcl-2. Biomed Pharmacother.
80:8–15. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xing B and Ren C: Tumor-suppressive
miR-99a inhibits cell proliferation via targeting of TNFAIP8 in
osteosarcoma cells. Am J Transl Res. 8:1082–1090. 2016.PubMed/NCBI
|
|
22
|
Zhang R, Yan S, Wang J, Deng F, Guo Y, Li
Y, Fan M, Song Q, Liu H, Weng Y and Shi Q: miR-30a regulates the
proliferation, migration, and invasion of human osteosarcoma by
targeting Runx2. Tumour Biol. 37:3479–3488. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu Z, Wang S, Zhu J, Yang Q, Dong H and
Huang J: MicroRNA-544 down-regulates both Bcl6 and Stat3 to inhibit
tumor growth of human triple negative breast cancer. Biol Chem.
397:1087–1095. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu H, Mastriani E, Yan ZQ, Yin SY, Zeng
Z, Wang H, Li QH, Liu HY, Wang X, Bao HX, et al: SOX7 co-regulates
Wnt/β-catenin signaling with Axin-2: Both expressed at low levels
in breast cancer. Sci Rep. 6:261362016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yanaka Y, Muramatsu T, Uetake H, Kozaki K
and Inazawa J: miR-544a induces epithelial-mesenchymal transition
through the activation of WNT signaling pathway in gastric cancer.
Carcinogenesis. 36:1363–1371. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wei Z, Zhong M, Guo Y, Wang Y, Ren M and
Wang Z: Expression of β-catenin and AXIN2 in ameloblastomas.
Contemp Oncol (Pozn). 17:250–256. 2013.PubMed/NCBI
|
|
27
|
Koinuma K, Yamashita Y, Liu W, Hatanaka H,
Kurashina K, Wada T, Takada S, Kaneda R, Choi YL, Fujiwara SI, et
al: Epigenetic silencing of AXIN2 in colorectal carcinoma with
microsatellite instability. Oncogene. 25:139–146. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Y, Xin H, Han Z, Sun H, Gao N and Yu
H: MicroRNA-374a promotes esophageal cancer cell proliferation via
Axin2 suppression. Oncol Rep. 34:1988–1994. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang JJ, Wang CY, Hua L, Yao KH, Chen JT
and Hu JH: miR-107 promotes hepatocellular carcinoma cell
proliferation by targeting Axin2. Int J Clin Exp Pathol.
8:5168–5174. 2015.PubMed/NCBI
|
|
30
|
Kim JS, Park SY, Lee SA, Park MG, Yu SK,
Lee MH, Park MR, Kim SG, Oh JS, Lee SY, et al: MicroRNA-205
suppresses the oral carcinoma oncogenic activity via
down-regulation of Axin-2 in KB human oral cancer cell. Mol Cell
Biochem. 387:71–79. 2014. View Article : Google Scholar : PubMed/NCBI
|
